More May Not Be Better: Comparison of Oncologic Outcomes Following Induction Chemotherapy Plus Chemoradiation and Chemoradiation Alone for Esophageal Adenocarcinoma
We could not detect added oncologic benefit in survival or pathologic complete response with IC over CRT alone for resectable esophageal and GEJ cancer. Biomarker driven prospective studies exploring the optimal perioperative treatment regimens are warranted.
Authors
- Sunnie S. Kim (ORCID: https://orcid.org/0009-0008-3871-5112)
- John D. Mitchell (ORCID: https://orcid.org/0000-0003-0045-2288)
- Jane Read
- Christina M. Stuart (ORCID: https://orcid.org/0000-0002-9851-8486)
- Robert A. Meguid (ORCID: https://orcid.org/0000-0003-2646-4252)
- Martin D. McCarter (ORCID: https://orcid.org/0000-0001-8174-1713)
- Benedetto Mungo
- Elliott J. Yee (ORCID: https://orcid.org/0009-0006-6807-2168)
- Ioannis A. Ziogas (ORCID: https://orcid.org/0000-0002-6742-6909)
- Jeffrey R. Olsen
Institutions
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1002/jso.27952
- Citations
- 2
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.15